Variable | EIF4A2 | ANKRD46 | ||||
---|---|---|---|---|---|---|
 | Low (n = 21) | High (n = 78) | P* | Low (n = 47) | High (n = 52) | P* |
Age (years) | Â | Â | Â | Â | Â | Â |
   < 48 | 8 | 39 | 0.332 | 23 | 24 | 0.782 |
   ≥ 48 | 13 | 39 |  | 24 | 28 |  |
Pathologic grade | Â | Â | Â | Â | Â | Â |
   I | 2 | 20 | 0.115 | 14 | 10 | 0.221 |
   II, III | 19 | 58 |  | 33 | 42 |  |
Clinical stage** | Â | Â | Â | Â | Â | Â |
   I, II | 15 | 61 | 0.514 | 41 | 37 | 0.051 |
   III | 6 | 17 |  | 6 | 15 |  |
Lymph node status | Â | Â | Â | Â | Â | Â |
   Metastasis | 14 | 43 | 0.342 | 23 | 34 | 0.098 |
   No Metastasis | 7 | 35 |  | 24 | 18 |  |
ER status | Â | Â | Â | Â | Â | Â |
Negative | 12 | 36 | 0.371 | 18 | 32 | 0.021 |
Positive | 9 | 42 | Â | 29 | 20 | Â |
PR status | Â | Â | Â | Â | Â | Â |
Negative | 11 | 28 | 0.170 | 11 | 29 | 0.001 |
Positive | 10 | 50 | Â | 36 | 23 | Â |
CerbB2 status | Â | Â | Â | Â | Â | Â |
0,1+ | 17 | 41 | 0.019 | 29 | 18 | 0.832 |
2+,3+ | 4 | 37 | Â | 31 | 21 | Â |